United States · 
Who invested in Solu Therapeutics?
Solu Therapeutics's investors include DCVC, Eli Lilly, Alexandria Venture Investments and Longwood Fund.
United States · Series A startup
Who invested in Solu Therapeutics
Funding summaryUpdated 26 Oct 2026
$41Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $41MApr 2025
- Investors
- 4
The rounds
- Apr 2025
Everyone who backed them
Alexandria Venture InvestmentsVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Solu Therapeutics
How much has Solu Therapeutics raised?
Solu Therapeutics has raised $41M across 1 round since 2025.
When did Solu Therapeutics last raise?
Solu Therapeutics's most recent round was a Series A of $41M in Apr 2025.
What was Solu Therapeutics's biggest round?
Its most recent round, $41M in Apr 2025, is also its largest on record.
Who backed Solu Therapeutics first?
Solu Therapeutics's first round on record, in Apr 2025, was backed by DCVC, Eli Lilly and Alexandria Venture Investments and 1 others.
What stage is Solu Therapeutics at?
Solu Therapeutics's latest named round is a Series A, in Apr 2025.
Where is Solu Therapeutics based?
Solu Therapeutics is based in the United States.
Companies like Solu Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.